Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

797
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
797
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

661
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
661
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

462
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
462
Actuarial Approach01:20

Actuarial Approach

335
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
335
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.1K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.1K
Cancer Prevention02:59

Cancer Prevention

8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe obstructive sleep apnoea can be accurately diagnosed in primary care centres.

NPJ primary care respiratory medicine·2026
Same author

Transcriptomic profiling of endothelial progenitor cells in post-COVID-19 patients: Insights at 3 and 6-month post-infection.

iScience·2025
Same author

Four-year respiratory consequences of COVID-19 related pneumonia: a longitudinal cohort study.

BMC pulmonary medicine·2025
Same author

Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection.

Infection·2024
Same author

Long-term respiratory consequences of COVID-19 related pneumonia: a cohort study.

BMC pulmonary medicine·2023
Same author

Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension.

Antioxidants (Basel, Switzerland)·2023

Related Experiment Video

Updated: Feb 27, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk Analysis.

Rafael Abós-Herràndiz1, Teresa Rodriguez-Blanco2, Isabel Garcia-Allas1

  • 1Catalan Health Institute (ICS), Division of Primary Health Care, Department of Health, Barcelona, Catalonia, Spain.

Canadian Respiratory Journal
|July 7, 2017
PubMed
Summary

Mortality from asbestos-related diseases is significant, with mesothelioma being a primary cause. Identifying risk factors like age and exposure is crucial for prevention and improved patient follow-up in affected communities.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

953
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Feb 27, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

953
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Environmental Health
  • Occupational Medicine
  • Epidemiology

Background:

  • The overall mortality associated with asbestos-related diseases, both malignant and nonmalignant, is not well-defined.
  • This study aimed to determine the incidence and identify risk factors for all asbestos-related deaths.

Purpose of the Study:

  • To assess the incidence and risk factors for asbestos-related mortality in an exposed population.
  • To inform preventive strategies and clinical management for individuals exposed to asbestos.

Main Methods:

  • A cohort of 544 patients from an asbestos-exposed community in Barcelona, Spain, was studied from 1970 to 2006.
  • Competing risk regression using subdistribution hazard analysis was employed to identify risk factors for asbestos-related outcomes.

Main Results:

  • Asbestos-related deaths occurred in 30.7% of patients, with mesothelioma accounting for 57.5% of these fatalities.
  • The incidence rate of asbestos-related death post-diagnosis was 3,600 per 100,000 person-years.
  • Pleural and peritoneal mesothelioma were diagnosed in 16.0% and 3.3% of patients, respectively.

Conclusions:

  • Key risk factors for asbestos-related death include age, sex, household exposure, cumulative nonmalignant asbestos-related disease, and specific malignant pathologies.
  • The findings underscore the necessity for community-level preventive measures.
  • Enhanced clinical follow-up protocols are recommended for patients with asbestos exposure.